DK0473564T3 - Antikoagulant kombination af LACI og sulfatiserede polysaccharider - Google Patents

Antikoagulant kombination af LACI og sulfatiserede polysaccharider

Info

Publication number
DK0473564T3
DK0473564T3 DK91870132.7T DK91870132T DK0473564T3 DK 0473564 T3 DK0473564 T3 DK 0473564T3 DK 91870132 T DK91870132 T DK 91870132T DK 0473564 T3 DK0473564 T3 DK 0473564T3
Authority
DK
Denmark
Prior art keywords
laci
sulfated polysaccharides
combination
anticoagulant
anticoagulant combination
Prior art date
Application number
DK91870132.7T
Other languages
English (en)
Inventor
Tze-Chein Wun
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of DK0473564T3 publication Critical patent/DK0473564T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91870132.7T 1990-08-27 1991-08-26 Antikoagulant kombination af LACI og sulfatiserede polysaccharider DK0473564T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57308390A 1990-08-27 1990-08-27

Publications (1)

Publication Number Publication Date
DK0473564T3 true DK0473564T3 (da) 1996-04-15

Family

ID=24290576

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91870132.7T DK0473564T3 (da) 1990-08-27 1991-08-26 Antikoagulant kombination af LACI og sulfatiserede polysaccharider

Country Status (10)

Country Link
EP (1) EP0473564B1 (da)
JP (1) JPH0733336B2 (da)
AT (1) ATE135585T1 (da)
CA (1) CA2049873C (da)
DE (1) DE69118056T2 (da)
DK (1) DK0473564T3 (da)
ES (1) ES2085462T3 (da)
GR (1) GR3020312T3 (da)
IE (1) IE913004A1 (da)
PT (1) PT98779B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
CA2194443A1 (en) * 1994-07-07 1996-01-25 Dana R. Abendschein Method of attenuating arterial stenosis
ATE226249T1 (de) * 1994-08-05 2002-11-15 Chiron Corp Herstellung des inhibitors fuer die komplexbildung des gewebefaktors
US5589359A (en) 1994-08-05 1996-12-31 Chiron Corporation Chimeric proteins
PT1602667E (pt) * 1995-06-07 2007-07-13 Searle Llc Formulação aquosa que compreende tfpi e agentes de solubilização
AU759412B2 (en) * 1995-06-07 2003-04-17 G.D. Searle & Co. Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
AU2003200506B2 (en) * 1995-06-07 2007-01-18 G.D. Searle Llc Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
US5772629A (en) * 1995-10-23 1998-06-30 Localmed, Inc. Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
WO1997022347A1 (en) * 1995-12-18 1997-06-26 Stichting Sanquin Bloedvoorziening Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
KR20040040489A (ko) 2001-10-15 2004-05-12 카이론 코포레이션 조직 인자 경로 억제제（ｔｆｐｉ）의 저용량 투여에 의한패혈증의 치료
EP1654283B1 (en) 2003-08-13 2011-07-13 Novartis Vaccines and Diagnostics, Inc. Improved method of purifying tfpi and tfpi analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87172A (en) * 1987-07-23 1994-12-29 Univ Washington A method of inhibiting the isolation of a purer tissue factor
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co ANDC of human tissue factor inhibitor
ATE135044T1 (de) * 1990-01-25 1996-03-15 Univ Washington Faktor x-laci-hybridprotein

Also Published As

Publication number Publication date
JPH04257524A (ja) 1992-09-11
CA2049873C (en) 2001-12-04
ATE135585T1 (de) 1996-04-15
JPH0733336B2 (ja) 1995-04-12
EP0473564A1 (en) 1992-03-04
DE69118056D1 (de) 1996-04-25
PT98779A (pt) 1992-07-31
PT98779B (pt) 1999-06-30
GR3020312T3 (en) 1996-09-30
IE913004A1 (en) 1992-03-11
DE69118056T2 (de) 1996-10-24
ES2085462T3 (es) 1996-06-01
EP0473564B1 (en) 1996-03-20
CA2049873A1 (en) 1992-02-28

Similar Documents

Publication Publication Date Title
DK0473564T3 (da) Antikoagulant kombination af LACI og sulfatiserede polysaccharider
SE9101957D0 (sv) Blandningar av polysackarider med laag molekylvikt samt framstaellning och anvaendning av desamma
ES2102131T3 (es) Elastomeros termoplasticos fluorados que tienen superiores propiedades mecanicas y elasticas.
DK1284740T3 (da) Profylaktisk og terapeutisk behandling af infektiöse sygdomme, autoimmunsygdomme og allergiske sygdomme med monosaccharidbaserede forbindelser
DE69206111D1 (de) Herstellungsverfahren von Turbinen- oder Verdichtershaufeln.
DE69105713D1 (de) Prothetische femorale komponente.
DK0426221T3 (da) Optisk forstærkningsenhed med lav støj og refleksion af pumpeeffekten
FI925101A0 (fi) Foerfarande foer framstaellning av mikrokapslar som innehaoller i ett matrismaterial inkapslat aromaemne och med foerfarandet framstaellda produkter
DK1427427T3 (da) Derivater af delvist desulfaterede glucosaminoglykaner som heparanasehæmmere med antiangiogen virkning og uden antikoaguleringsvirkning
ATE143810T1 (de) Hepatozytwachstumsfaktor enthaltende mittel
FI913870A0 (fi) Kondensator foersedd med folioutspraong och foerfarande foer dess framstaellning.
DK0424351T3 (da) Anvendelse af modificeret heparin-cofaktor II
ES2093458T3 (es) Procedimiento para la obtencion de 1,1,1,3,3-pentafluorpropano.
IT9041752A0 (it) Nuovi derivati dell'eparina
DE69724923D1 (de) Niedermolekulare Fukane mit blutgerinnungshemmender, antithrombinischer und antithrombotischer Wirkung
FR2659116B1 (fr) Compresseur multi-etages de volume variable autolubrifiant.
DK0984785T3 (da) Anvendelse af oligosaccharid til forhindring af blodkoagulation i ekstrakorporale blodkredslöb
FR2707871B1 (fr) Prothèse bicondylienne du genou du type à glissement.
FR2692140B1 (fr) Prothèse partielle unicompartimentaire de genou.
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
DK0427402T3 (da) Anvendelse af cyclodextriner og derivater deraf
ITMI912602A0 (it) Flangia di un subbio, particolarmente di un subbio di ordito o di catena
FR2668059B1 (fr) Implant femoral.
DK0393530T3 (da) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oner og -thioner og deres anvendelse til forebyggelse eller behandling af AIDS
DK0569383T3 (da) Lavmolekylære, sulfaterede poly-beta-2,6-fructofuranosaner og deres anvendelse til behandling af degenerative ledsygdomme